United Capital Financial Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.11M | Buy |
5,671
+738
| +15% | +$153K | 0.01% | 762 |
|
|
2026
Q1 | $1.11M | Sell |
4,933
-52
| -1% | -$13K | 0.01% | 723 |
|
|
2025
Q4 | $1.2M | Sell |
4,985
-98
| -2% | -$25.1K | 0.01% | 676 |
|
|
2025
Q3 | $1.39M | Sell |
5,083
-213
| -4% | -$58.2K | 0.01% | 554 |
|
|
2025
Q2 | $1.37M | Sell |
5,296
-39
| -0.7% | -$9.3K | 0.01% | 521 |
|
|
2025
Q1 | $1.19M | Buy |
5,335
+47
| +0.9% | +$11K | 0.01% | 533 |
|
|
2024
Q4 | $1.21M | Sell |
5,288
-171
| -3% | -$41.2K | 0.01% | 516 |
|
|
2024
Q3 | $1.33M | Buy |
5,459
+36
| +0.7% | +$8.04K | 0.01% | 479 |
|
|
2024
Q2 | $1.04M | Sell |
5,423
-1,518
| -22% | -$308K | 0.01% | 517 |
|
|
2024
Q1 | $1.37M | Sell |
6,941
-268
| -4% | -$49.1K | 0.01% | 498 |
|
|
2023
Q4 | $1.24M | Buy |
7,209
+5,508
| +324% | +$846K | 0.01% | 507 |
|
|
2023
Q3 | $252K | Buy |
+1,701
| New | +$308K | ﹤0.01% | 760 |
|
|
2023
Q1 | – | Sell |
-1,808
| Closed | -$376K | – | 1054 |
|
|
2022
Q4 | $376K | Buy |
1,808
+81
| +5% | +$17.8K | ﹤0.01% | 816 |
|
|
2022
Q3 | $377K | Sell |
1,727
-109
| -6% | -$24.8K | ﹤0.01% | 839 |
|
|
2022
Q2 | $385K | Buy |
+1,836
| New | +$391K | ﹤0.01% | 868 |
|
|
2022
Q1 | – | Sell |
-4,326
| Closed | -$1.13M | – | 1211 |
|
|
2021
Q4 | $1.13M | Sell |
4,326
-342
| -7% | -$88.7K | 0.01% | 651 |
|
|
2021
Q3 | $1.23M | Buy |
4,668
+326
| +8% | +$89.1K | 0.01% | 620 |
|
|
2021
Q2 | $1.07M | Sell |
4,342
-203
| -4% | -$42.7K | 0.01% | 675 |
|
|
2021
Q1 | $882K | Sell |
4,545
-61
| -1% | -$12.2K | ﹤0.01% | 700 |
|
|
2020
Q4 | $979K | Buy |
4,606
+36
| +0.8% | +$7.18K | 0.01% | 682 |
|
|
2020
Q3 | $783K | Buy |
4,570
+2
| +0% | +$369 | 0.01% | 722 |
|
|
2020
Q2 | $877K | Sell |
4,568
-28
| -0.6% | -$4.58K | 0.01% | 701 |
|
|
2020
Q1 | $677K | Sell |
4,596
-235
| -5% | -$37.4K | 0.01% | 720 |
|
|
2019
Q4 | $749K | Buy |
4,831
+184
| +4% | +$26.5K | ﹤0.01% | 881 |
|
|
2019
Q3 | $628K | Sell |
4,647
-3,895
| -46% | -$510K | ﹤0.01% | 885 |
|
|
2019
Q2 | $1.04M | Sell |
8,542
-80,911
| -90% | -$8.96M | 0.01% | 797 |
|
|
2019
Q1 | $9.3M | Sell |
89,453
-23,664
| -21% | -$2.44M | 0.07% | 302 |
|
|
2018
Q4 | $12.9M | Sell |
113,117
-8,075
| -7% | -$865K | 0.1% | 212 |
|
|
2018
Q3 | $14M | Sell |
121,192
-4,807
| -4% | -$527K | 0.1% | 226 |
|
|
2018
Q2 | $13.1M | Sell |
125,999
-6,553
| -5% | -$663K | 0.1% | 241 |
|
|
2018
Q1 | $13.1M | Sell |
132,552
-11,588
| -8% | -$1.1M | 0.1% | 231 |
|
|
2017
Q4 | $12.4M | Sell |
144,140
-10,522
| -7% | -$869K | 0.1% | 255 |
|
|
2017
Q3 | $11.9M | Sell |
154,662
-4,986
| -3% | -$381K | 0.1% | 245 |
|
|
2017
Q2 | $12.4M | Buy |
159,648
+2,932
| +2% | +$210K | 0.11% | 219 |
|
|
2017
Q1 | $11.3M | Sell |
156,716
-1,451
| -0.9% | -$100K | 0.11% | 228 |
|
|
2016
Q4 | $9.81M | Buy |
158,167
+12,663
| +9% | +$776K | 0.1% | 259 |
|
|
2016
Q3 | $9.43M | Sell |
145,504
-8,646
| -6% | -$575K | 0.09% | 273 |
|
|
2016
Q2 | $9.71M | Buy |
154,150
+555
| +0.4% | +$32.7K | 0.1% | 243 |
|
|
2016
Q1 | $8.88M | Buy |
153,595
+3,008
| +2% | +$170K | 0.1% | 228 |
|
|
2015
Q4 | $8.09M | Buy |
150,587
+4,664
| +3% | +$263K | 0.09% | 244 |
|
|
2015
Q3 | $7.44M | Buy |
145,923
+7,133
| +5% | +$384K | 0.09% | 237 |
|
|
2015
Q2 | $7.82M | Sell |
138,790
-55,483
| -29% | -$3.5M | 0.09% | 260 |
|
|
2015
Q1 | $12.4M | Sell |
194,273
-50,860
| -21% | -$3.3M | 0.15% | 167 |
|
|
2014
Q4 | $13.7M | Buy |
245,133
+5,400
| +2% | +$282K | 0.21% | 124 |
|
|
2014
Q3 | $11.8M | Buy |
239,733
+331
| +0.1% | +$16.9K | 0.21% | 125 |
|
|
2014
Q2 | $12.1M | Buy |
239,402
+2,993
| +1% | +$148K | 0.22% | 112 |
|
|
2014
Q1 | $10.6M | Buy |
+236,409
| New | +$10.6M | 0.23% | 104 |
|
Other funds holding RMD
United Capital Financial Advisors's RMD Position: Q2 2026 in Review
United Capital Financial Advisors increased its ResMed (RMD) stake by 15% in Q2 2026, buying an estimated $153K and bringing the position to 5,671 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #762.
United Capital Financial Advisors first reported a position in RMD in Q1 2014 and has held it in 47 quarters since. The position peaked at $14M in Q3 2018. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- United Capital Financial Advisors held 5,671 shares of ResMed worth $1.11M as of Q2 2026.
- United Capital Financial Advisors bought 738 ResMed shares in Q2 2026, an estimated $153K.
- ResMed made up 0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #762 holding.
- United Capital Financial Advisors first reported a position in ResMed in Q1 2014 and has held it in 47 quarters since.
- United Capital Financial Advisors's ResMed position peaked at $14M in Q3 2018.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.